✦ LIBER ✦

351 POSTER Activity of the histone deacetylase (HDAC) inhibitor PXD101 in preclinical prostate cancer studies

✍ Scribed by M. Jeffers; X. Qian; E. Mills; W. LaRochelle; H. Lichenstein; G. Ara

Book ID: 118623979
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 54 KB
Volume: 4
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(06)70356-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Activity of the histone deacetylase inhi

Activity of the histone deacetylase inhibitor belinostat (PXD101) in preclinical models of prostate cancer

✍ Xiaozhong Qian; Gulshan Ara; Evan Mills; William J. LaRochelle; Henri S. Lichens 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 751 KB

## Abstract Histone deacetylase inhibitors (HDACi) represent a promising new class of anticancer agents. In the current investigation, we examined the activity of the HDACi belinostat in preclinical models of prostate cancer. __In vitro__ proliferation assays demonstrated that belinostat potently i

The histone deacetylase inhibitor PXD101

The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models

✍ Young-Soon Na; Kyung-Ah Jung; Seung-Mi Kim; Yong Sang Hong; Min-Hee Ryu; Se Jin 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 874 KB

584 POSTER Histone deacetylase inhibitor

584 POSTER Histone deacetylase inhibitors abrogate the levels and activity of estrogen receptor (ER) α and histone deacetylase (HDAC) 6 in human breast cancer cells (BCCs)

✍ W. Fiskus; A. Mohapatra; P. Bali; M. Balasis; R. Rao; P. Atadja; J. Wu; K. Bhall 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB

404 POSTER A phase I study of oral admin

404 POSTER A phase I study of oral administration of the histone deacetylase (HDAC) inhibitor belinostat in patients (pts) with advanced solid tumors

✍ W. Kelly; D. Petrylak; G. Blumenschein; U. Lassen; P. Buhl Jensen; J. DeBono 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 64 KB

Identification of Novel, Selective, and

Identification of Novel, Selective, and Stable Inhibitors of Class II Histone Deacetylases. Validation Studies of the Inhibition of the Enzymatic Activity of HDAC4 by Small Molecules as a Novel Approach for Cancer Therapy

✍ Ontoria, Jesus M.; Altamura, Sergio; Di Marco, Annalise; Ferrigno, Federica; Lau 📂 Article 📅 2009 🏛 American Chemical Society 🌐 English ⚖ 849 KB

1234 POSTER A First in Man Phase 1 Study

1234 POSTER A First in Man Phase 1 Study of JNJ-26481585, a Novel Oral Histone Deacetylase Inhibitor (HDACi) in Advanced Cancer Patients -Evidence of Target Modulation, Antitumour Activity and Additional Safety Data in an Expanded Patient Cohort

✍ A. Omlin; B. Venugopal; R. Kristeleit; K. Shah; N. Fourneau; P. Hellemans; J. de 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB